{ "schemaVersion": 2, "eyebrow": "Hematology", "title": "Vitamin B12 Deficiency", "summary": "Confirm clinically meaningful cobalamin deficiency, treat neurologic or severe hematologic presentations urgently, and define whether dietary insufficiency, autoimmune gastritis, or intestinal malabsorption requires lifelong replacement and surveillance.", "seoDescription": "Point-of-care approach to vitamin B12 deficiency: diagnostic confirmation, urgent neurologic presentations, cause-directed testing, replacement, and follow-up.", "clinicalQuestion": "How should physicians confirm, treat, and prevent recurrence of vitamin B12 deficiency according to severity and cause?", "specialty": "Hematology", "audience": "U.S. physicians and medical trainees", "tags": [ "vitamin B12 deficiency", "cobalamin deficiency", "methylmalonic acid", "pernicious anemia", "autoimmune gastritis", "subacute combined degeneration", "macrocytosis" ], "keyTakeaways": [ "Do not exclude vitamin B12 deficiency because anemia or macrocytosis is absent; neurologic and neuropsychiatric disease may be the presenting phenotype. [19][20]", "Use serum methylmalonic acid to support deficiency when serum B12 is low-normal or clinical suspicion persists; elevated methylmalonic acid supports cellular B12 deficiency. [3][9][12]", "Admit and initiate urgent intensive parenteral replacement for marked symptomatic anemia, pancytopenia, subacute combined spinal degeneration, or cognitive impairment/dementia attributed to B12 deficiency. [4]", "Test for anti-intrinsic-factor antibodies when B12 deficiency suggests autoimmune gastritis; intrinsic-factor failure produces persistent malabsorption and generally requires lifelong replacement. [1][8][12][24]", "High-dose oral cyanocobalamin can be effective, including in many malabsorptive states, but parenteral therapy is preferred initially for severe deficiency, neurologic disease, or unreliable oral adherence. [4][15][17]" ], "sections": [ { "id": "triage-and-initial-assessment", "eyebrow": "First encounter", "heading": "Identify presentations requiring immediate parenteral treatment", "intro": "Severity determines whether diagnostic sampling can precede, but should not delay, replacement.", "paragraphs": [ "Hospitalize patients with pancytopenia, marked symptomatic anemia, or severe neurologic manifestations including subacute combined spinal degeneration, ataxia, dementia, or cognitive impairment, and begin urgent intensive cyanocobalamin or hydroxocobalamin therapy. Neurologic injury may be irreversible despite adequate replacement, making treatment urgency greater when gait dysfunction, weakness, sensory loss, or cognitive decline is progressive. [4][20]", "Before the first dose when feasible, obtain CBC with hematocrit, reticulocyte count, serum B12, folate, and iron studies; collect confirmatory metabolite testing before replacement if the diagnosis is uncertain. Do not defer treatment in a patient with rapidly progressive neurologic or hematologic disease merely to complete testing. [15][13]", "A megaloblastic anemia phenotype supports the diagnosis, but neurologic complications can occur without severe anemia. The inverse association between hemoglobin concentration and neurologic severity means a relatively preserved hemoglobin level does not provide reassurance in a patient with posterior-column symptoms, peripheral neuropathy, cognitive decline, or myelopathy. [20]" ], "bullets": [ "Escalate urgently for progressive gait disturbance, incoordination, weakness, cognitive decline, or suspected myelopathy; these features can represent central or peripheral demyelinating disease from B12 deficiency. [2][18][22]", "Do not use response to empiric B12 alone as the sole diagnostic strategy when alternative causes of myelopathy, neuropathy, cytopenias, or cognitive decline remain plausible. B12 deficiency has heterogeneous presentations and is vulnerable to misattribution. [19][24]" ], "subsections": [], "table": { "caption": "Clinical severity determines urgency and route of initial replacement. [4][15]", "columns": [ "Presentation", "Immediate action", "Rationale" ], "rows": [ [ "Pancytopenia or marked symptomatic anemia", "Hospitalize; initiate urgent intensive parenteral cyanocobalamin or hydroxocobalamin. [4]", "Severe hematologic disease requires acute treatment. [4]" ], [ "Subacute combined spinal degeneration, ataxia, dementia, or cognitive impairment", "Hospitalize and give urgent intensive parenteral therapy; obtain baseline diagnostic specimens if this does not delay treatment. [4][15]", "Neurologic deficits may become irreversible despite replacement. [4]" ], [ "Mild-to-moderate manifestations or asymptomatic deficiency", "Begin maintenance-level cyanocobalamin or hydroxocobalamin while establishing cause and feasibility of oral adherence. [4]", "Maintenance replacement can prevent hematologic and neurologic complications. [4]" ] ] } }, { "id": "confirm-biochemical-deficiency", "eyebrow": "Diagnosis", "heading": "Confirm functional deficiency when the serum B12 result is equivocal", "intro": "Interpret serum B12 in the clinical context rather than as an isolated exclusion test.", "paragraphs": [ "Start with serum B12 in patients with macrocytosis, anemia, neurologic symptoms, neuropsychiatric symptoms, or relevant nutritional and gastrointestinal risk factors. A low-normal B12 concentration can still reflect deficiency; an elevated serum methylmalonic acid supports functional cobalamin deficiency and is particularly useful when the initial B12 value does not match the clinical phenotype. [9][12][19]", "Measure homocysteine as an adjunctive metabolic marker when available, but interpret it with methylmalonic acid rather than treating it as B12-specific: both homocysteine and methylmalonic acid are elevated in B12 deficiency. [3][19] Check folate concurrently because folate and B12 deficiency produce morphologically indistinguishable megaloblastic anemia, while neurologic injury is a key discriminator favoring B12 deficiency. [15][20]", "If initial testing makes deficiency unlikely but symptoms or signs persist, repeat the original B12 test or obtain methylmalonic acid after 3 to 6 months. This interval applies to unresolved clinical suspicion rather than to progressive neurologic or hematologic illness, which warrants immediate reassessment and treatment. [12][13]" ], "bullets": [ "Order CBC, reticulocyte count, folate, and iron studies with B12 evaluation to characterize cytopenias and coexisting nutritional deficiencies. [15]", "Use clinical response as supportive follow-up evidence, not as a substitute for evaluating other etiologies of cognitive decline, neuropathy, or spinal cord disease. [19][24]" ], "subsections": [ { "heading": "When to broaden beyond B12 deficiency", "paragraphs": [ "Persistent or progressive neurologic dysfunction despite biochemical correction should prompt reassessment for alternative central and peripheral nervous system disorders rather than repeated empiric dosing alone. B12-related neurologic syndromes overlap with myelopathy, neuropathy, autonomic dysfunction, optic atrophy, mood and behavioral changes, psychosis, memory impairment, and cognitive decline. [20]" ], "bullets": [] } ], "table": { "caption": "Biochemical and clinical findings that alter the next diagnostic step. [3][9][12][15][19]", "columns": [ "Finding", "Interpretation", "Next step" ], "rows": [ [ "Low serum B12 with compatible anemia, neuropathy, or neuropsychiatric findings", "Vitamin B12 deficiency is likely. [19]", "Obtain baseline folate, iron studies, CBC, and reticulocyte count if not already collected; begin replacement according to severity. [15]" ], [ "Low-normal serum B12 with compatible phenotype", "Serum B12 alone may not exclude deficiency. [9][19]", "Measure serum methylmalonic acid; elevation supports deficiency. [9]" ], [ "Elevated methylmalonic acid and homocysteine", "Pattern supports B12 deficiency. [3]", "Identify dietary versus irreversible malabsorptive cause and institute replacement. [24]" ], [ "Initial testing unlikely for deficiency but persistent symptoms at 3-6 months", "Initial testing may require reassessment. [12]", "Repeat the initial test or obtain methylmalonic acid. [12]" ] ] } }, { "id": "define-the-cause", "eyebrow": "Etiology", "heading": "Separate reversible dietary deficiency from intrinsic-factor and ileal malabsorption", "intro": "The cause determines duration, route, and intensity of recurrence prevention.", "paragraphs": [ "Classify the deficiency as dietary insufficiency, food-bound cobalamin malabsorption, autoimmune gastritis with intrinsic-factor failure, or terminal-ileal disease/resection. Clinically important deficiency is more likely to progress when intrinsic-factor-dependent absorption fails than when dietary intake alone is inadequate; most persistent causes evolve over years. [7][24]", "Order anti-intrinsic-factor antibody testing in B12 deficiency when autoimmune gastritis is suspected. Autoimmune injury to oxyntic gastric parietal cells reduces intrinsic factor and produces B12 malabsorption; autoimmune gastritis is the disease process historically associated with pernicious anemia. [8][12][13]", "Elicit prior terminal ileal resection, terminal ileitis, Crohn disease, and small-intestinal bacterial overgrowth. Patients with terminal ileal disease or resection are prone to B12 deficiency, and B12 replacement may be oral or parenteral depending on disease severity, absorption reliability, and response. [9][15] Deficiency may appear years after bariatric surgery because body stores delay clinical expression. [9]", "Review diet and medication exposure. Strict vegan or vegetarian diets increase risk and justify maintenance-level replacement when deficiency risk is high. Long-term proton-pump inhibitor or histamine-2 receptor antagonist use is associated with lower B12 levels and should trigger review of ongoing indication, especially in older adults. [4][6][19]" ], "bullets": [ "Treat autoimmune gastritis, intrinsic-factor deficiency, and substantial ileal loss as persistent causes requiring an ongoing replacement plan rather than a finite nutritional course. [1][8][24]", "For dietary deficiency, correct the dietary pattern and continue maintenance replacement; oral therapy is cost-effective for diet-related deficiency. [4][5]", "In patients with inflammatory bowel disease, screen for B12 deficiency when there is current or prior terminal ileal disease, terminal ileal resection, or risk of small-intestinal bacterial overgrowth. [9]" ], "subsections": [ { "heading": "Autoimmune gastritis and gastric surveillance", "paragraphs": [ "Document autoimmune gastritis explicitly rather than using anemia terminology alone, because the condition is irreversible and current guidance includes monitoring for gastric cancer in affected patients. Coordinate gastroenterology assessment for the surveillance strategy when autoimmune gastritis is identified. [11][13]" ], "bullets": [] } ], "table": { "caption": "Etiologic patterns that determine recurrence risk and long-term replacement. [1][4][6][8][9][12][24]", "columns": [ "Etiologic branch", "Key discriminator", "Management implication" ], "rows": [ [ "Dietary insufficiency", "Vegan or strict vegetarian dietary pattern without evidence of irreversible gastrointestinal disease. [4]", "Use maintenance-level replacement and correct dietary intake; oral cyanocobalamin is cost-effective for diet-related deficiency. [4][5]" ], [ "Autoimmune gastritis / intrinsic-factor failure", "Positive anti-intrinsic-factor antibody testing in a compatible patient; parietal-cell injury reduces intrinsic factor. [8][12]", "Plan lifelong B12 therapy and address autoimmune-gastritis complications, including gastric cancer monitoring. [1][11]" ], [ "Terminal-ileal disease or resection", "Crohn disease with terminal ileitis, terminal ileal resection, or small-intestinal bacterial overgrowth risk. [9]", "Replace B12 orally or parenterally according to absorption, clinical severity, and response; anticipate recurrent deficiency. [9][15]" ], [ "Food-bound cobalamin malabsorption or acid suppression exposure", "Older age, chronic gastrointestinal illness, or long-term PPI/H2-receptor antagonist exposure. [4][6][7]", "Review medication necessity and use a sustainable maintenance regimen with biochemical and clinical follow-up. [4][19]" ] ] } }, { "id": "replacement-therapy", "eyebrow": "Treatment", "heading": "Choose parenteral or high-dose oral replacement by severity, absorption, and adherence", "intro": "Initial route should protect neurologic recovery while allowing a sustainable long-term regimen.", "paragraphs": [ "Use intramuscular replacement initially for severe cobalamin deficiency, especially when neurologic disease, marked anemia, pancytopenia, or malabsorption is present. Cyanocobalamin is commonly used in the United States; hydroxocobalamin is used more commonly in Europe and is particularly useful in malabsorptive states. [4][15][16]", "For hydroxocobalamin treatment of B12-deficiency anemia, a cited regimen is 1 mg intramuscularly every other day for 5 to 10 doses, followed by 1 mg every 3 months for maintenance. Intensive regimens over approximately 1 month are recommended for severe hematologic or neurologic disease, followed by ongoing maintenance treatment. [4][16]", "High-dose oral cyanocobalamin, including 1,000 mcg daily, can replenish B12 through passive absorption and has evidence of effectiveness comparable to intramuscular treatment in many patients, including those with Crohn disease and pernicious anemia. Select oral therapy only when the patient is clinically stable and can reliably adhere; choose parenteral therapy when oral adherence is doubtful or an irreversible malabsorptive cause is accompanied by severe disease. [1][4][15][17][21]", "Avoid assuming that intranasal or sublingual preparations are interchangeable with established oral or intramuscular regimens; evidence and optimal dosing for those routes remain limited. [4] Cyanocobalamin is contraindicated in Leber hereditary optic neuropathy and is reported as contraindicated in renal insufficiency; confirm product-specific contraindications and select formulation accordingly. [5]" ], "bullets": [ "Continue lifelong therapy for pernicious anemia or other persistent malabsorption. [1][24]", "Use maintenance-level replacement for asymptomatic people at high risk, including strict vegetarians, vegans, older adults, and patients with chronic gastrointestinal disease, to prevent potentially irreversible complications. [4]", "Pregnancy and lactation are not reasons to stop indicated replacement; ongoing or new B12 treatment for documented deficiency is mandatory and considered safe. [5]" ], "subsections": [ { "heading": "Selecting oral therapy", "paragraphs": [ "Oral therapy is a practical choice for dietary deficiency and for stable patients who prefer tablets and can adhere to daily dosing. In pernicious anemia, prospective treatment with oral cyanocobalamin 1,000 mcg daily has been studied over one year with serial B12, homocysteine, and methylmalonic acid assessments, supporting oral therapy as an option when adherence and follow-up are reliable. [5][21]" ], "bullets": [] } ], "table": { "caption": "Replacement route selection for vitamin B12 deficiency. [1][4][15][16][17][21]", "columns": [ "Clinical setting", "Preferred initial approach", "Maintenance consideration" ], "rows": [ [ "Severe neurologic or hematologic deficiency", "Urgent intensive intramuscular cyanocobalamin or hydroxocobalamin. [4][15]", "Continue maintenance replacement after intensive treatment; use a lifelong regimen for persistent malabsorption. [1][4]" ], [ "Hydroxocobalamin regimen", "1 mg IM every other day for 5-10 doses. [16]", "Then 1 mg IM every 3 months. [16]" ], [ "Stable dietary deficiency", "High-dose oral cyanocobalamin is reasonable when adherence is reliable. [4][17]", "Maintenance-level oral replacement plus dietary correction. [4][5]" ], [ "Stable pernicious anemia or Crohn disease with reliable adherence", "Consider oral cyanocobalamin 1,000 mcg daily as an alternative to IM therapy. [4][21]", "Monitor clinical and biochemical response; maintain lifelong therapy when malabsorption persists. [1][21]" ], [ "Poor adherence, cognitive impairment, frailty, or major social barriers", "Favor intramuscular replacement. [13]", "Establish a supervised or self-injection maintenance plan when feasible. [5][13]" ] ] } }, { "id": "monitoring-and-nonresponse", "eyebrow": "Follow-up", "heading": "Monitor clinical recovery, biochemical correction, and relapse risk", "intro": "Follow-up must verify both correction and the adequacy of the long-term delivery plan.", "paragraphs": [ "At follow-up, assess the presenting phenotype directly: CBC and reticulocyte response for anemia or cytopenias; gait, proprioceptive symptoms, strength, paresthesias, and cognition for neurologic disease; and adherence to oral therapy or injection access. Follow-up is central because prevention of relapse depends on identifying the cause and maintaining effective replacement. [15][24]", "For oral therapy in pernicious anemia, serial total plasma B12, homocysteine, and plasma methylmalonic acid have been used to assess biochemical response over one year. Persistent metabolite elevation, recurrent symptoms, or failure of hematologic recovery should prompt review of adherence, dosing route, ongoing malabsorption, coexisting folate or iron deficiency, and alternative diagnoses. [15][21][24]", "Do not stop replacement solely because anemia corrects. Neurologic disease may coexist with minimal hematologic abnormality, and irreversible causes such as autoimmune gastritis, intrinsic-factor failure, and ileal resection require ongoing therapy to prevent recurrence. [1][20][24]" ], "bullets": [ "Reassess the indication for chronic acid suppression in patients with B12 deficiency and ongoing PPI or H2-receptor antagonist exposure. [6][19]", "Teach self-injection when an ongoing parenteral regimen is selected and the patient can perform it safely; individualized injection frequency can improve feasibility. [5]", "Escalate persistent neurologic symptoms despite repletion for neurologic evaluation and reassessment of the differential diagnosis. [20][24]" ], "subsections": [], "table": { "caption": "Follow-up targets after treatment initiation. [5][15][21][24]", "columns": [ "Domain", "What to reassess", "Action if inadequate" ], "rows": [ [ "Hematologic response", "CBC, hematocrit, and reticulocyte count. [15]", "Reassess adherence, competing iron or folate deficiency, diagnosis, and adequacy of replacement route. [15][24]" ], [ "Biochemical response", "Serum B12; consider methylmalonic acid and homocysteine, particularly with oral treatment. [21]", "Confirm adherence and consider parenteral replacement if oral delivery is unreliable or ineffective. [15][21]" ], [ "Neurologic recovery", "Gait, coordination, sensory symptoms, weakness, and cognition. [2][20]", "Urgently reconsider alternative neurologic diagnoses if symptoms progress or do not fit the treatment response. [20][24]" ], [ "Recurrence prevention", "Whether the cause is dietary and reversible versus intrinsic-factor or ileal malabsorption. [1][9][24]", "Continue lifelong therapy for persistent malabsorption; maintain dietary-risk supplementation when risk remains. [1][4]" ] ] } } ], "faq": [], "references": [ { "number": 1, "title": "Vitamin B12 Deficiency", "detail": "www.nejm.org", "url": "https://www.nejm.org/doi/pdf/10.1056/nejmcp1113996", "authors": "www.nejm.org", "host": "www.nejm.org" }, { "number": 2, "title": "Neurologic Manifestations of Vitamin B12 Deficiency", "detail": "www.nejm.org", "url": "https://www.nejm.org/doi/abs/10.1056/NEJMicm020588", "authors": "www.nejm.org", "host": "www.nejm.org" }, { "number": 3, "title": "AB0628 Vitamin B12, Homocysteine and Methylmalonic ...", "detail": "ard.bmj.com", "url": "https://ard.bmj.com/content/74/Suppl_2/1109.1", "authors": "ard.bmj.com", "host": "ard.bmj.com" }, { "number": 4, "title": "Vitamin B12 deficiency - Management Approach | BMJ Best Practice", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-gb/822/management-approach", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com" }, { "number": 5, "title": "Vitamin B12", "detail": "www.bmj.com", "url": "https://www.bmj.com/content/bmj/383/bmj-2022-071725.full.pdf", "authors": "www.bmj.com", "host": "www.bmj.com" }, { "number": 6, "title": "Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory | Scientific Reports", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-019-53622-3", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 7, "title": "Vitamin B12 deficiency – A 21st century perspective", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S1470211824019808", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 8, "title": "Have You Considered Pernicious Anemia?", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0736467922006485", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 9, "title": "Vitamin B12 Deficiency - an overview", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/vitamin-b12-deficiency", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 10, "title": "Pernicious anemia predominates among Mexican adults ...", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0034837626000082", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 11, "title": "Vitamin B12 deficiency in over 16s: diagnosis and ...", "detail": "www.nice.org.uk", "url": "https://www.nice.org.uk/guidance/ng239", "authors": "www.nice.org.uk", "host": "www.nice.org.uk" }, { "number": 12, "title": "Guideline Vitamin B12 deficiency in over 16s", "detail": "www.nice.org.uk", "url": "https://www.nice.org.uk/guidance/gid-ng10176/documents/draft-guideline", "authors": "www.nice.org.uk", "host": "www.nice.org.uk" }, { "number": 13, "title": "Recommendations | Vitamin B12 deficiency in over 16s: diagnosis and management | Guidance | NICE", "detail": "www.nice.org.uk", "url": "https://www.nice.org.uk/guidance/ng239/chapter/recommendations", "authors": "www.nice.org.uk", "host": "www.nice.org.uk" }, { "number": 14, "title": "B12 and folate deficiency: Scenario: Management of anaemia", "detail": "cks.nice.org.uk", "url": "https://cks.nice.org.uk/topics/anaemia-b12-folate-deficiency/management/management", "authors": "cks.nice.org.uk", "host": "cks.nice.org.uk" }, { "number": 15, "title": "Vitamin B12 (Cobalamin) - StatPearls - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=69909fe9549459423d462513", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 16, "title": "Hydroxocobalamin - StatPearls - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=69b0e1451a63f1308c5ed229", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 17, "title": "Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency - Vidal‐Alaball, J - 2005 | Cochrane Library", "detail": "www.cochranelibrary.com", "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004655.pub2/references", "authors": "www.cochranelibrary.com", "host": "www.cochranelibrary.com" }, { "number": 18, "title": "Rare sensory and autonomic disturbances associated with ...", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022510X09007424", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 19, "title": "The Many Faces of Cobalamin (Vitamin B12) Deficiency", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S2542454819300335", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 20, "title": "Vitamin B12, folic acid, and the nervous system", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S1474442206705981", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 21, "title": "Oral vitamin B12 supplementation in pernicious anemia", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0002916524004842", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 22, "title": "Biomarkers of Nutrition for Development (BOND): Vitamin B ...", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0022316622164266", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 23, "title": "Vitamin B12 deficiency and cognitive impairment", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S266645932500040X", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 24, "title": "How I treat cobalamin (vitamin B12) deficiency", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0006497120598431", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" } ], "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.", "citations": [ { "number": 1, "title": "Vitamin B12 Deficiency", "detail": "www.nejm.org", "url": "https://www.nejm.org/doi/pdf/10.1056/nejmcp1113996", "authors": "www.nejm.org", "host": "www.nejm.org", "snippet": "by SP Stabler · 2013 · Cited by 2107 — For patients with pernicious anemia or malabsorption, lifelong vitamin B12 therapy is indicated. • High-dose oral vitamin B12 tablets (1000", "score": 0.6747586 }, { "number": 2, "title": "Neurologic Manifestations of Vitamin B12 Deficiency", "detail": "www.nejm.org", "url": "https://www.nejm.org/doi/abs/10.1056/NEJMicm020588", "authors": "www.nejm.org", "host": "www.nejm.org", "snippet": "by K Scherer · 2003 · Cited by 36 — A 56-year-old woman presented with a four-month history of progressive cognitive decline, weakness, incoordination, and gait disturbance.", "score": 0.5010992 }, { "number": 3, "title": "AB0628 Vitamin B12, Homocysteine and Methylmalonic ...", "detail": "ard.bmj.com", "url": "https://ard.bmj.com/content/74/Suppl_2/1109.1", "authors": "ard.bmj.com", "host": "ard.bmj.com", "snippet": "by B Bitik · 2015 — Vitamin B12 (VitB12) deficiency is associated with neurologic manifestations. Elevation in the serum concentrations of both homocysteine (Hcy) and methylmalonic ...Read more", "score": 0.53079647 }, { "number": 4, "title": "Vitamin B12 deficiency - Management Approach | BMJ Best Practice", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-gb/822/management-approach", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com", "snippet": "Title: Vitamin B12 deficiency - Management Approach | BMJ Best Practice\nPatients with severe haematological or neurological symptoms of vitamin B12 deficiency require immediate treatment with an intensive regimen of cyanocobalamin or hydroxocobalamin over 1 month, followed by ongoing maintenance dos", "score": 0.79939574 }, { "number": 5, "title": "Vitamin B12", "detail": "www.bmj.com", "url": "https://www.bmj.com/content/bmj/383/bmj-2022-071725.full.pdf", "authors": "www.bmj.com", "host": "www.bmj.com", "snippet": "doi: 10.1136/bmj.l1865. pmid: 31076395 13 Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiencyCochrane Database Syst Rev 2018;3:CD004655.pmid: 29543316 the bmj | BMJ 2023;383:e071725 | doi: 10.1136/bmj-2022-071725 6 PRACT", "score": 0.70531887 }, { "number": 6, "title": "Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory | Scientific Reports", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-019-53622-3", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "CAS \n PubMed \n PubMed Central \n Google Scholar\n28. Heidelbaugh, J. J. Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications. Ther Adv Drug Saf 4, 125–133, (2013).\n\n Article \n CAS \n PubMed \n PubMed Central \n Google Scholar\n29. V", "score": 0.7451949 }, { "number": 7, "title": "Vitamin B12 deficiency – A 21st century perspective", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S1470211824019808", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Vitamin B 12 deficiency is a common condition which can present with non-specific clinical features, and in severe cases with neurological or haematological abnormalities. Although classically caused by pernicious anaemia, this condition now accounts for a minority of cases and vitamin B 12 deficien", "score": 0.77261686 }, { "number": 8, "title": "Have You Considered Pernicious Anemia?", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0736467922006485", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "2026, Frontiers in Immunology Show abstract Background Pernicious anemia (PA) is a severe clinical consequence of autoimmune gastritis. It results from immune-mediated damage to gastric parietal cells in the oxyntic mucosa. This process leads to intrinsic factor deficiency and subsequent vitamin B ", "score": 0.7237202 }, { "number": 9, "title": "Vitamin B12 Deficiency - an overview", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/vitamin-b12-deficiency", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Because of storage of vitamin B12, development of vitamin B12 deficiency may manifest several years after bariatric surgery. Classic clinical manifestations are the multiple presentations of pernicious anemia or development of peripheral neuropathy. A low normal blood level of vitamin B12 can indica", "score": 0.72207695 }, { "number": 10, "title": "Pernicious anemia predominates among Mexican adults ...", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0034837626000082", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "by JM Moreno-Mirón · 2026 — Vitamin B12 deficiency is a reversible cause of hematologic and neurologic morbidity, Weight loss, gastrointestinal symptoms, and neurologic alterations were", "score": 0.6977124 }, { "number": 11, "title": "Vitamin B12 deficiency in over 16s: diagnosis and ...", "detail": "www.nice.org.uk", "url": "https://www.nice.org.uk/guidance/ng239", "authors": "www.nice.org.uk", "host": "www.nice.org.uk", "snippet": "You are here:\n\n# Vitamin B12 deficiency in over 16s: diagnosis and management\n\n## Overview\n\nThis guideline covers recognising, diagnosing and managing vitamin B12 deficiency in people aged 16 and over, including deficiency caused by autoimmune gastritis. It also covers monitoring for gastric cancer ", "score": 0.7352811 }, { "number": 12, "title": "Guideline Vitamin B12 deficiency in over 16s", "detail": "www.nice.org.uk", "url": "https://www.nice.org.uk/guidance/gid-ng10176/documents/draft-guideline", "authors": "www.nice.org.uk", "host": "www.nice.org.uk", "snippet": "DRAFT FOR CONSULTATION Vitamin B12 deficiency: NICE guideline DRAFT ([July 2023]) 1 of 41 1 NATIONAL INSTITUTE FOR HEALTH AND CARE 2 EXCELLENCE 3 Guideline 4 Vitamin B12 deficiency in over 16s: diagnosis 5 and management 6 Draft for consultation, July 2023 7 8 This guideline covers the diagnosis and", "score": 0.7067782 }, { "number": 13, "title": "Recommendations | Vitamin B12 deficiency in over 16s: diagnosis and management | Guidance | NICE", "detail": "www.nice.org.uk", "url": "https://www.nice.org.uk/guidance/ng239/chapter/recommendations", "authors": "www.nice.org.uk", "host": "www.nice.org.uk", "snippet": "Autoimmune gastritis is sometimes referred to as pernicious anaemia. Pernicious anaemia can be a consequence of chronic, severe vitamin B12 deficiency, including deficiency caused by autoimmune gastritis. However, pernicious anaemia in its true sense (that is, life-threatening anaemia) is now extrem", "score": 0.70263255 }, { "number": 14, "title": "B12 and folate deficiency: Scenario: Management of anaemia", "detail": "cks.nice.org.uk", "url": "https://cks.nice.org.uk/topics/anaemia-b12-folate-deficiency/management/management", "authors": "cks.nice.org.uk", "host": "cks.nice.org.uk", "snippet": "How should I treat a person with vitamin B12 deficiency anaemia? · Offer either intramuscular or oral vitamin B12 replacement (based on clinical judgement and ...Read more", "score": 0.44275752 }, { "number": 15, "title": "Vitamin B12 (Cobalamin) - StatPearls - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=69909fe9549459423d462513", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "Title: Vitamin B12 (Cobalamin) - StatPearls - NCBI Bookshelf\n# Vitamin B12 (Cobalamin). Vitamin B12 (cobalamin) is an essential vitamin and medication used to manage and treat pernicious anemia, ileal resection, treatment of spinal cord myelopathy, and other conditions. This activity reviews the ind", "score": 0.8443195 }, { "number": 16, "title": "Hydroxocobalamin - StatPearls - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=69b0e1451a63f1308c5ed229", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "Title: Hydroxocobalamin - StatPearls - NCBI Bookshelf\nHydroxocobalamin is a medication used in the management and treatment of vitamin B12 deficiency and acute cyanide toxicity. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, ", "score": 0.7707586 }, { "number": 17, "title": "Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency - Vidal‐Alaball, J - 2005 | Cochrane Library", "detail": "www.cochranelibrary.com", "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004655.pub2/references", "authors": "www.cochranelibrary.com", "host": "www.cochranelibrary.com", "snippet": "Title: Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency - Vidal‐Alaball, J - 2005 | Cochrane Library\n| | Cochrane review language Select your preferred language for Cochrane reviews and other content. | | Website language Select your preferred language for the Cochrane ", "score": 0.7409441 }, { "number": 18, "title": "Rare sensory and autonomic disturbances associated with ...", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022510X09007424", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "by P Puntambekar · 2009 · Cited by 57 — Vitamin B12 deficiency is an important nutritional disorder causing neurological manifestations of myelopathy, neuropathy and dementia.", "score": 0.62633044 }, { "number": 19, "title": "The Many Faces of Cobalamin (Vitamin B12) Deficiency", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S2542454819300335", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "In clinical practice, many cases of vitamin B 12 deficiency are overlooked or sometimes even misdiagnosed. In this review, we describe the heterogeneous disease spectrum of patients with vitamin B 12 deficiency in whom the diagnosis was either based on low serum B 12 levels, elevated biomarkers like", "score": 0.61140573 }, { "number": 20, "title": "Vitamin B12, folic acid, and the nervous system", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S1474442206705981", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "## Neurology of vitamin-B12 deficiency\n\nKinnier Wilson wrote the best review of the older detailed description of the overlapping syndromes of peripheral neuropathy, SCD, autonomic dysfunction, optic atrophy, mood and behaviour changes, psychosis, memory impairment, and cognitive decline.6 Recent st", "score": 0.6041426 }, { "number": 21, "title": "Oral vitamin B12 supplementation in pernicious anemia", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0002916524004842", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "### Methods\n\nWe enrolled participants diagnosed with incident vitamin B12 deficiency related to PA. The diagnosis of PA was based on the presence of classical immune gastritis and of anti-intrinsic factor and/or antiparietal cell antibodies. To evaluate the vitamin B12 status, we measured total plas", "score": 0.60077465 }, { "number": 22, "title": "Biomarkers of Nutrition for Development (BOND): Vitamin B ...", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0022316622164266", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "by LH Allen · 2018 · Cited by 422 — Clinical attributes of neurologic symptoms of B12 deficiency. •. Neurologic complications result from demyelination of peripheral and central nerves.", "score": 0.57408494 }, { "number": 23, "title": "Vitamin B12 deficiency and cognitive impairment", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S266645932500040X", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Cognitive impairment, a prevalent issue in aging populations, significantly affects quality of life and public health systems. Among various contributing factors, Vitamin B12 deficiency emerges as a critical yet modifiable risk factor, impacting neurological and cognitive health. Vitamin B12, an ess", "score": 0.528315 }, { "number": 24, "title": "How I treat cobalamin (vitamin B12) deficiency", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0006497120598431", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "The challenges in medical management of cobalamin deficiency lie in attention to the unique pathophysiology that underlies cobalamin deficiency, more than in the mechanics of therapy. The central physiologic principles are that clinically important deficiency is more likely to occur (and progress) w", "score": 0.5150107 } ], "publishedAt": "2026-08-24T18:33:22.708462+00:00", "updatedAt": "2026-08-24T18:33:22.708462+00:00", "readingMinutes": 6, "slug": "vitamin-b12-deficiency" }